Comparison of intraplatelet reactive oxygen species, mitochondrial damage, and platelet apoptosis after implantation of three continuous flow left ventricular assist devices: HeartMate II, Jarvik 2000, and HeartWare

ASAIO Journal

Volumn 61, Issue 3, 2015, Pages 244-252

  Mondal, Nandan K ^a   Sorensen, Erik N ^b   Feller, Erika D ^a   Pham, Si M ^a   Griffith, Bartley P ^a   Wu, Zhongjun J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

heart failure; intraplatelet reactive oxygen species; left ventricular assist devices; mitochondrial damage; platelet apoptosis

Indexed keywords

CARDIOLOGY; CELL DEATH; MITOCHONDRIA; OXYGEN; PLATELETS; REACTIVE OXYGEN SPECIES;

CLINICAL COMPLICATIONS; CONTINUOUS FLOWS; DEVICE DESIGN; DIFFERENT EFFECTS; HEART FAILURE; MITOCHONDRIAL DAMAGE; RIGHT VENTRICULAR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES;

LEFT VENTRICULAR ASSIST DEVICES;

REACTIVE OXYGEN METABOLITE;

ADULT; ANTICOAGULANT THERAPY; APOPTOSIS; ARTICLE; BLOOD CHEMISTRY; BLOOD CLOTTING PARAMETERS; CELL DAMAGE; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; DEVICE INFECTION; FEMALE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART ASSIST DEVICE; HEART FAILURE; METABOLISM; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; APOPTOSIS; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84937575247     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000208     Document Type: Article

References (31)

1. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 355: 1873-1884, 2006
2. Lietz K. Destination therapy: Patient selection and current outcomes. J Card Surg. 25: 462-471, 2010
3. Lahpor J, Khaghani A, Hetzer R, et al. European results with a continuous-flow ventricular assist device for advanced heartfailure patients. Eur J Cardiothorac Surg. 37: 357-361, 2010
4. Crow S, John R, Boyle A, et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatilEleft ventricular assist devices. J Thorac Cardiovasc Surg. 137: 208-215, 2009
5. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 25: 352-356, 2010
6. Siegenthaler MP, Martin J, van dEloo A, et al. Implantation of the permanent Jarvik-2000 left ventricular assist device: A singlecenteRexperience. J Am Coll Cardiol. 39: 1764-1772, 2002
7. Frazier OH, Myers TJ, Westaby S, et al. Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 237: 631-636, 2003
8. Haj-Yahia S, Birks EJ, Rogers P, et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg. 134: 199-203, 2007
9. Nawata K, Nishimura T, Kyo S, et al. Outcomes of midterm circulatory support by left ventricular assist device implantation with descending aortic anastomosis. J Artif Organs. 13: 197-201, 2010
10. Slaughter MS, Rogers JG, Milano CA, et al. HeartMate II Investigators: Advanced heart failure treated with continuousflow left ventricular assist device. N Engl J Med. 361: 2241-2251, 2009
11. Rogers JG, Aaronson KD, Boyle AJ, et al. HeartMate II Investigators: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 55: 1826-1834, 2010
12. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant. 29: 1-10, 2010
13. Pagani FD, Miller LW, Russell SD, et al. HeartMate II Investigators: Extended mechanical circulatory support with a continuousflow rotary left ventricular assist device. J Am Coll Cardiol. 54: 312-321, 2009
14. Lalonde SD, Alba AC, Rigobon A, et al. Clinical differences between continuous flow ventricular assist devices: A comparison between HeartMate II and HeartWare HVAD. J Card Surg. 28: 604-610, 2013
15. Leytin V, Allen DJ, Mykhaylov S, et al. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys ReScommun. 320: 303-310, 2004
16. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J. 65: 245-248, 1991
17. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol. 301: H2181-H2190, 2011
18. Mondal NK, Sorensen E, Hiivala N, FelleRe, Griffith B, Wu ZJ. Oxidative stress, DNA damage and repair in heart failure patients after implantation of continuous flow left ventricular assist devices. Int J Med Sci. 10: 883-893, 2013
19. Andriollo-Sanchez M, Hininger-Favier I, Meunier N, et al. Agerelated oxidative stress and antioxidant parameters in middleaged and oldeReuropean subjects: the ZENITH study. Eur J Clin Nutr 59(Suppl 2): S58-S62, 2005
20. Donohue FJ. Ageing, smoking and oxidative stress. Thorax. 61: 461-462, 2006
21. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 107: 1058-1070, 2010
22. Harrison DG, Gongora MC. Oxidative stress and hypertension. Med Clin North Am. 93: 621-635, 2009
23. Banerjee A, Mondal NK, Das D, Ray MR. Neutrophilic inflammatory response and oxidative stress in premenopausal women chronically exposed to indoor air pollution from biomass burning. Inflammation. 35: 671-683, 2012
24. Hakim J. Reactive oxygen species and inflammation. C R Seances Soc Biol Fil. 187: 286-295, 1993
25. Redout EM, Wagner MJ, Zuidwijk MJ, et al. Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species. Cardiovasc Res. 75: 770-781, 2007
26. Pietraforte D, Vona R, Marchesi A, et al. Redox control of platelet functions in physiology and pathophysiology. Antioxid Redox Signal. 21: 177-193, 2014
27. Hu J, Mondal NK, Sorensen EN, et al. Platelet glycoprotein Iba ectodomain shedding and non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist devices. J Heart Lung Transplant. 33: 71-79, 2014
28. Zharikov S, Shiva S. Platelet mitochondrial function: From regulation of thrombosis to biomarker of disease. Biochem Soc Trans. 41: 118-123, 2013
29. Lopez JJ, Salido GM, Gómez-Arteta E, Rosado JA, Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost. 5: 1283-1291, 2007
30. Leytin V. Apoptosis in the anucleate platelet. Blood Rev. 26: 51-63, 2012
31. Gyulkhandanyan AV, Mutlu A, Freedman J, Leytin V. Markers of platelet apoptosis: Methodology and applications. J Thromb Thrombolysis. 33: 397-411, 2012